Zyfoqam

Zyfoqam (Linagliptin) is an oral diabetes medication used to improve blood sugar control in adults with type 2 diabetes. It belongs to the DPP-4 inhibitor class and is taken once daily. This medication works with diet and exercise to help manage blood glucose levels.

Linagliptin is primarily used to help manage blood sugar levels in adults with type 2 diabetes. It works by increasing the levels of incretin hormones, which help regulate blood sugar. This medication is often prescribed alongside diet and exercise to improve glycemic control. It may also be used in combination with other diabetes medications, as determined by a healthcare provider.

Linagliptin helps maintain steady blood sugar levels throughout the day, reducing spikes after meals. Many users report improved energy levels and reduced fatigue associated with high blood sugar. It does not typically cause weight gain and may support better overall glucose management when used consistently.

Store Zyfoqam at room temperature, away from moisture and direct light. Keep this medication out of reach of children and pets. Do not use if the packaging is damaged or the tablets appear discolored. Always check the expiration date before use to ensure effectiveness.

Linagliptin may interact with certain medications, including strong CYP3A4 inhibitors like ketoconazole or ritonavir. Alcohol consumption may affect blood sugar levels, so moderation is advised. Inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.